PHUONG TRAN: Open Payments
NPI 1265860571 · PORT ARTHUR, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,726 in 88 payments from 14 companies in 2025. Trend: 2023 $1,450 · 2024 $1,761 · 2025 $1,726
Food & beverage: $1,726
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $320 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $249 |
| Novo Nordisk Inc | 13 | $217 |
| PFIZER INC. | 8 | $172 |
| Dexcom, Inc. | 10 | $159 |
| AstraZeneca Pharmaceuticals LP | 8 | $158 |
| Lilly USA, LLC | 5 | $104 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $100 |
| Corcept Therapeutics | 1 | $80 |
| Axsome Therapeutics, Inc. | 3 | $60 |
Products named: TRINTELLIX, Dexcom G6 Transmitter, QULIPTA, ELIQUIS, Wegovy, VRAYLAR, CAPLYTA, AIRSUPRA.
Industry payments across TX — which companies pay providers there.
